Daiichi and GAIA join forces to commercialise digital cardiovascular therapy [Yahoo! Finance]
DAIICHI SANKYO S/ADR (DSNKY)
NASDAQ:AMEX Investor Relations:
daiichisankyo.com/media_investors/investor_relations/index.html
Company Research
Source: Yahoo! Finance
Daiichi Sankyo's European faction and health technology company GAIA have banded together to commercialise a digital therapeutic designed to support adults with hypercholesterolaemia. Under the terms of the agreement, Daiichi will claim the exclusive rights to the tool – called lipodia – marking the first potential expansion of the company's cardiovascular portfolio into the digital health market. The partnership will originally centre around the German healthcare market, though Daiichi plans to expand lipodia's presence to “all major markets on the continent”. Lipodia acts by combining individually patient-tailored, evidence-based behavioural health and psychotherapeutic approaches to encourage users to make sustained and long-term changes to their lifestyle. The system is designed to complement a patient's pharmaceutical treatment regimen, while promoting prolonged behavioural changes to improve health and reduce a patient's risk of cardiovascular disease (CVD). “Digital ther
Show less
Read more
Impact Snapshot
Event Time:
DSNKY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DSNKY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DSNKY alerts
High impacting DAIICHI SANKYO S/ADR news events
Weekly update
A roundup of the hottest topics
DSNKY
News
- GAIA and Daiichi Sankyo Europe Enter Exclusive Partnership to Launch Next-Generation Digital Therapeutic for Cardiovascular Care in Europe. [Yahoo! Finance]Yahoo! Finance
- GAIA and Daiichi Sankyo Europe Enter Exclusive Partnership to Launch Next-Generation Digital Therapeutic for Cardiovascular Care in Europe.Business Wire
- ESPR to Boost Cardiovascular Portfolio With Corstasis Buyout for $75M [Yahoo! Finance]Yahoo! Finance
- Esperion to acquire Corstasis for cardiovascular franchise expansion [Yahoo! Finance]Yahoo! Finance
- Antibody-drug Conjugates (ADCs) in Oncology Market Competitive Landscape Report 2026: Comprehensive Insights About 200+ Companies and 220+ Drugs by Product Type, Stage, and Route of Administration [Yahoo! Finance]Yahoo! Finance